Literature DB >> 31867538

Ultrasensitive Detection of Severe Fever with Thrombocytopenia Syndrome Virus Based on Immunofluorescent Carbon Dots/SiO2 Nanosphere-Based Lateral Flow Assay.

Lai-Di Xu1, Qing Zhang2, Shou-Nian Ding1, Jing-Juan Xu3, Hong-Yuan Chen3.   

Abstract

Sensitive detection of severe fever with thrombocytopenia syndrome virus (SFTSV) by a point-of-care assay is of great significance for promoting clinical diagnosis. In this work, ultrasensitive detection of SFTSV was achieved by using fluorescent carbon dots/SiO2 nanospheres (CSNs) as reporters for a lateral flow assay. The prepared CSNs were resistant to extreme environments and had strong stability. The uniform CSNs with the size of about 200 nm were obtained by differential centrifugation. Their absolute quantum yields in the aqueous and solid phases are 56.3 and 36.6%, respectively. The excellent fluorescent properties of CSNs make the test strips more sensitive and have a longer assay lifetime. Thus, the visual detection limit of the lateral flow test strip based on immunofluorescent CSN (iCSN) was as low as 10 pg/mL SFTSV nucleoprotein. The sensitivity of this assay is 2 orders of magnitude higher than that of the colloidal gold-based lateral flow test strip. Besides, the assay owns good reproducibility and high specificity. Then, iCSN-based lateral flow test strips were evaluated in real samples of human serum of patients with satisfactory results. Furthermore, this assay has a general prospect for other fluorescent immunochromatography applications.
Copyright © 2019 American Chemical Society.

Entities:  

Year:  2019        PMID: 31867538      PMCID: PMC6921636          DOI: 10.1021/acsomega.9b03130

Source DB:  PubMed          Journal:  ACS Omega        ISSN: 2470-1343


Introduction

Severe fever with thrombocytopenia syndrome (SFTS) is an emerging infectious disease with fever, thrombocytopenia, and leukopenia as the main clinical symptoms.[1] Since 2010, it has caused human infection and death in central and eastern China. A novel Bunia virus, also known as SFTS virus (SFTSV), has been found to be the cause of the disease. SFTSV is a single negative strand RNA virus whose genome contains three RNA circular fragments of large (L), medium (M), and small (S). The S fragment is an ambisense, encoding a nucleoprotein (NP) and a nonstructural protein. NP can encapsulate three RNA genomic fragments of SFTSV and play an important role in viral transcription and replication.[2] In recent years, different SFTSV detection methods have been reported,[3−5] for example, the ELISA detection of SFTSV has been reported, which could detect an antigen concentration of 1 ng/mL. However, the lengthy and cumbersome operations and expensive instruments limit their practical application. In our previous work, colloidal gold-based lateral flow assay was used for simple, convenient, and rapid detection of SFTSV with a visual detection limit of 1 ng/mL SFTSV NP.[6] As the most famous point-of-care (POC) assay strategy, lateral flow assay has been successfully utilized for detecting small molecules,[7,8] nucleic acids,[9] proteins,[10,11] and so on. The main advantages of the lateral flow test strip are speed, low cost, simplicity, convenience, and no need for trained personnel and expensive equipment.[11] The lateral flow test strips labeled with gold nanoparticles have been widely used and commercialized. This is due to their excellent stability, incomparable biocompatibility, simpler synthesis, visual results, and more. However, the inherent low signal-to-noise ratio of gold nanoparticles limits their lower detection limit.[12] Up to now, researchers have further developed lateral flow test strips using magnetic materials,[13,14] carbon materials,[15−17] fluorescent quantum dots (QDs),[18,19] upconversion phosphors,[20,21] and organic fluorescent dyes[22] as signal materials to improve sensitivity. Among them, the integration of fluorescent QDs into nanospheres will further improve the sensitivity, because the fluorescence intensity of a fluorescent nanosphere is much higher than that of a single QD. Furthermore, fluorescent nanospheres possess good biocompatibility, high stability in a complex matrix, and convenient manipulation compared with traditional semiconductor QDs.[23] Over the past decade, many researchers have worked on the construction and application of semiconductor QDs-based fluorescence nanospheres and have achieved a series of achievements.[24−31] Different construction methods always have various limitations.[23,32] For instance, after embedding high-quality oil QDs into nanospheres, QDs may leak out of the sphere pores in nonpolar suspended media. The incorporating of QDs during the nanosphere formation process usually requires careful control of the reaction conditions, and QDs may aggregate during the polymerization, which may affect their fluorescence properties. The process of assembling QDs onto the surface of the nanospheres is cumbersome and time-consuming, and it usually requires an additional shell to cover the resulting fluorescent spheres for protection and conjugation. Most studies on carbon materials as signal reporters for test strips mainly include carbon colloids and carbon nanotubes, which can help to visually observe the test results.[15,16,33−35] They are more sensitive, stable, and environmentally friendly than gold particles. Fluorescent carbon dots (CDs) are a member of QDs and are a new class of zero-dimensional nanomaterials in the carbon family. Compared with conventional semiconductor QDs, fluorescent CDs are superior in terms of chemical inertness, photostability, low cytotoxicity, and biocompatibility.[36−38] Therefore, CDs can be widely used in biological imaging,[38−42] drug release,[43] as a sensor,[44] photocatalyst,[45] and so on. Identically, the sensitivity of fluorescent carbon spheres as the test strip signal should be higher than that of fluorescent CDs as the test strip signal. To our best knowledge, there is no report of the use of fluorescent CDs-based nanospheres as tags on the lateral flow test strip. In this paper, we reported a rapid and sensitive method for the detection of SFTSV based on immunofluorescent CDs/SiO2 nanospheres (iCSNs) coupled with lateral flow test strips. The pathogen SFTSV of SFTS syndrome was used as a model virus. The initial symptoms of the SFTS syndrome are difficult to distinguish from viral infections such as influenza. Amino-rich fluorescent CDs/SiO2 nanospheres (CSNs) were synthesized by simple co-hydrolysis of silanized CDs with tetraethyl orthosilicate (TEOS). It has excellent fluorescence performance and stability, and greatly improves the sensitivity of the test strip. As expected, the detection limit of the assay was 10 pg/mL, which is 2 orders of magnitude lower than that of the colloidal gold immunochromatography assay, indicating that the iCSN-based test strip is promising in practice.

Results and Discussion

Characterization of the CSNs

CSNs were prepared by co-hydrolysis of CDs and TEOS. The disadvantage of this method is that the uniformity of the material is not good.[46] In order to overcome the non-uniformity of CSNs, CSNs with uniform morphology were obtained by differential centrifugation. Figure illustrates transmission electron microscopy (TEM) images of CSNs obtained by differential centrifugation. It can be seen that the particles exhibit good dispersibility, and as the separation speed increases from low to high, the size of the particles obtained at each rotational speed is remarkably reduced. The precipitate at 1500 rpm is mostly agglomerated particles as well as larger particles. When the rotating speed increased to 2000 rpm, there were still some agglomeration particles in the precipitate. When the rotating speed is further increased to 2500 rpm, the precipitated particle size is uniform and does not aggregate, and the average particle size is 200 nm. In addition, there are many smaller particles in the supernatant at 2500 rpm. The precipitate obtained at 2500 rpm was used as the next research object. The image of high-resolution TEM (HRTEM) in Figure E shows that CSNs own a mesoporous structure. CDs cannot be observed directly by HRTEM. This can be attributed to the molecular-level chemical dispersion of CD molecules in the silica matrix.[47] The incorporation of CDs into the formation of SiO2 nanospheres does not affect the fluorescence properties of CDs, and the strong fluorescence emitted by CSNs can be clearly visualized under a confocal fluorescent microscope (Figure F). The absolute quantum yields of CSNs in the aqueous phase and in the solid state are as high as 56.3 and 36.6%, respectively. Compared with the quantum yield of CDs of 47%,[39] the quantum yield of CSNs in the aqueous phase is higher. This indicates that the obtained CSNs have good stability and can be applied in harsh environments such as strong acids.
Figure 1

TEM images of the precipitates obtained by separating the CSNs at 1500 (A), 2000 (B), and 2500 rpm (C), and the supernatant at 2500 rpm (D). HRTEM (E) and confocal fluorescent image (F) of the precipitate obtained at 2500 rpm.

TEM images of the precipitates obtained by separating the CSNs at 1500 (A), 2000 (B), and 2500 rpm (C), and the supernatant at 2500 rpm (D). HRTEM (E) and confocal fluorescent image (F) of the precipitate obtained at 2500 rpm. As demonstrated in Figure , the intense blue light of the CD aqueous solution, the CSN aqueous solution, and the CSN powder can be observed under a 360 nm ultraviolet (UV) lamp. When excited in the range of 360–400 nm, the CD aqueous solution, the CSN aqueous solution, and the CSN powder exhibit strong blue photoluminescence (PL) centered at approximately 460 nm. When the excitation wavenumber is further increased, the emission of the CDs shifts from 465 to 524 nm and accompanied by a remarkable decrease in PL intensity, whereas the PL center of the CSN aqueous solution and the CSN powder does not move significantly; there is only a significant decrease in PL intensity. The PL centers of the CD aqueous solution, the CSN aqueous solution, and the CSN powder excited at 360 nm are 459, 462, and 463 nm, respectively. The optimum excitation wavelengths of the CD aqueous solution, the CSN aqueous solution, and the CSN powder are 369, 377, and 384 nm, respectively (Figure D). The red shift of the CSN aqueous solution relative to the CD aqueous solution is due to the increase in the rigidity of the CDs caused by CDs embedded in the rigid support of silica,[47] enhanced molecular structure rigidity, increased coplanarity, and enhanced emission.[48,49] The aggregation of CDs caused by solvent volatilization leads to further red shift of the CSN powder.[50] Energy resonance transfer or direct π–π interaction occurs because of the decrease of distance between adjacent CDs, which leads to the decrease of fluorescence efficiency.[51] In addition, N-β-(aminoethyl)-γ-aminopropyltrimethoxysilane (AEAPTMS), as a long-chain ligand, has a strong steric hindrance effect, and the CDs are embedded in the silica matrix, which makes the CDs support each other in the solid state and weakening the agglomeration effect, so the solid CSNs have fluorescence properties.
Figure 2

Emission spectra of (A) CDs in H2O, (B) CSNs in H2O, and (C) CSNs power at different excitation wavenumbers and the corresponding photos under sunlight (left insert) and a 360 nm UV light (right insert). Corresponding excitation spectra (D).

Emission spectra of (A) CDs in H2O, (B) CSNs in H2O, and (C) CSNs power at different excitation wavenumbers and the corresponding photos under sunlight (left insert) and a 360 nm UV light (right insert). Corresponding excitation spectra (D).

Fabrication of an iCSN-Based Lateral Flow Test Strip

To explore the feasibility of CSNs in sensitive fluorescence detection, CSNs were applied as optical labels on the lateral flow test strip. The first was to conjugate CSNs with the antibody. The composition of the CD is calculated by theory (Supporting Information, S4), which contains a large number of AEAPTMS. In the synthesis of CSNs, AEAPTMS participated in the reaction, so the CSNs are rich in amino groups. Although the glutaraldehyde method can directly bind the amino-rich CSNs to the antibody to form a complex, in the coupling process, agglomeration easily occurs among antibodies, antibodies and CSNs, and CSNs. Therefore, the particle size of the CSNs is greatly increased to the micron level, which is not suitable for immunochromatography (Figure S3A). This work was carried out by the succinic anhydride method, that is, the amino groups of CSNs were first reacted with succinic anhydride to form succinic acid half esters, which were then catalyzed by carbodiimide to form amide bonds with antibody (Figure A). The zeta potential of CDs/SiO2 spheres altered successively from the 23.5 to −37.8 mV (Figure B), indicating that the surface of the CSNs is rich in amino groups and then successfully grafted with the carboxyl groups. The CSNs were then modified with SFTSV monoclonal antibody (SmAb) and further blocked with bovine serum albumin (BSA) to form iCSNs as reporters, resulting in a partially neutralized zeta potential (−16.6 mV).
Figure 3

(A) Schematic illustration of the surface functionalization of the CSNs for lateral flow immunoassay. (B) Zeta potential of the CSNs at different stages of surface functionalization corresponding to panel (A).

(A) Schematic illustration of the surface functionalization of the CSNs for lateral flow immunoassay. (B) Zeta potential of the CSNs at different stages of surface functionalization corresponding to panel (A). As shown in Figure A, the pretreated sample pad, the nitrocellulose (NC) membrane, and the absorbent pad were adhered to the black plastic adhesive card to form a lateral flow test strip. The test (T) and control (C) lines of the NC membrane were coated with SmAb and goat antimouse IgG antibody, respectively. Figure B shows a schematic diagram of the SFTSV detection. The immunocomplex was formed by mixing the iCSNs with the sample and the mixture was then loaded into the sample pad to begin the test. The mixture was absorbed and migrated along the strip by capillary force. Through the interaction of specific antigen and antibody, the immunocomplex was captured by the T line on NC membrane to form the iCSN/SFTSV NP/SmAb sandwich structure. As the liquid continued to migrate, the free iCSNs moved further and were trapped by the goat antimouse IgG antibody on the C line to form the iCSN/IgG structure. Because of the strong PL performance of CSNs, signals could be observed under a UV lamp. If there is no SFTSV NP in the sample, iCSNs will flow through the T line instead of accumulating on the T line, only interacting with the goat antimouse IgG antibody on the C line. The determination of the results is illustrated in Figure A. The sample is considered positive when two fluorescence lines appeared on the T and C lines, and negative when only the C line is seen. An invalid test is the one with only a T line or no lines. Figure B shows a picture of positive and negative results. For a positive result, the T and C lines show blue light under a UV lamp. For a negative result, only the C line shows blue light under a UV lamp.
Figure 4

(A) Schematic illustration the configurations of iCSN-based test strip. (B) Schematic illustration of the detection of SFTSV using the iCSN-based test strip.

Figure 5

(A) Interpretation of results of the iCSN-based test strip. (B) Photos of iCSN-based test strips under UV lamp in the presence (left) and absence (right) of SFTSV.

(A) Schematic illustration the configurations of iCSN-based test strip. (B) Schematic illustration of the detection of SFTSV using the iCSN-based test strip. (A) Interpretation of results of the iCSN-based test strip. (B) Photos of iCSN-based test strips under UV lamp in the presence (left) and absence (right) of SFTSV.

Performance of the iCSN-Based Lateral Flow Test Strip

Sample pads were preimmersed in a buffer containing NaCl to eliminate false-positives before testing (Figure S3B). The possible reason is that secondary amines on CSNs and negatively charged amino acids on proteins may adsorb nonspecifically by electrostatic interactions. The salt dissociates into a positively charged and a negatively charged ionic state in water, which shields the protein from solid carriers and reduces nonspecific adsorption.[52,53] Under optimized detection condition, the sensitivity of the iCSN-based lateral flow test strip assay was investigated. First, a series of 60 μL SFTSV NP standards (1 μg/mL, 100 ng/mL, 10 ng/mL; 1 ng/mL, 100 pg/mL, 10 pg/mL, 0 pg/mL) were mixed with 10 μL of iCSN dispersion in a 0.5 mL centrifuge tube, respectively. The mixtures were then loaded separately onto the sample pads of the lateral flow test strips. As shown in Figure A, the blue C lines demonstrate the validity of the test results. The brightness of the T line decreases as the concentration of SFTSV NPs decreases. From 1 μg/mL to 1 ng/mL, the T lines emits very bright blue light, indicating positive results immediately. The colors of T lines are hard to be distinguished under low concentrations. In addition, only the C line is observed in the absence of SFTSV NP. Here, the visual detection limit for detecting SFTSV NPs is 10 pg/mL. The extremely low detection limit of the lateral flow test strip based on CSNs can be attributed to the excellent fluorescence characteristics of CSNs. This test can be quantified by estimating the brightness of the T line. As shown in Figure B, a linear relationship is obtained in a wide range of 10 pg/mL to 1 μg/mL with a linear correlation coefficient (R2) of 0.998. Compared to the previous SFTSV detection methods (Table S1), our method utilizes the novel cost-effective materials, saves time, and has a decent performance at the same time. This suggests that the iCSN-based lateral flow test strips have very promising prospects for high-sensitivity POC detection of viruses.
Figure 6

Sensitivity of the lateral flow assay for quantification of SFTSV NP. (A) Fluorescence pictures of the test strips for 1 μg/mL, 100 ng/mL, 10 ng/mL, 1 ng/mL, 100 pg/mL, 10 pg/mL, and 0 pg/mL standard SFTSV NP in buffer. (B) iCSN-based lateral flow test strip’s linear response for SFTSV NP detection; concentration range of 10 pg/mL to 1 μg/mL in buffer.

Sensitivity of the lateral flow assay for quantification of SFTSV NP. (A) Fluorescence pictures of the test strips for 1 μg/mL, 100 ng/mL, 10 ng/mL, 1 ng/mL, 100 pg/mL, 10 pg/mL, and 0 pg/mL standard SFTSV NP in buffer. (B) iCSN-based lateral flow test strip’s linear response for SFTSV NP detection; concentration range of 10 pg/mL to 1 μg/mL in buffer. To confirm the selectivity of the current immunoassay, blank phosphate buffer solution (PBS) and five different antigens with a concentration of 1 μg/mL were examined on the strip individually. The five antigens were HCG, AFP, CEA, CA125, and SFTSV NP. As shown in Figure , only the T line of the SFTSV NP shows obvious color. Accordingly, the fluorescence intensity for the SFTSV NP sample is conspicuously higher than that for those nonspecific protein samples. These results mean that the iCSN-based lateral flow test strip can specifically detect SFTSV.
Figure 7

Specificity research results to different interfering proteins.

Specificity research results to different interfering proteins. To evaluate the precision and reproducibility of the iCSN-based test strip, the intra-assay and interassay were performed using 1 μg/mL, 10 ng/mL, and 100 pg/mL SFTSV NP standard samples. The intra-assay CV and inter-assay CV are 4.8 and 7.1% (Table ), respectively, demonstrating that the method has high reproducibility and good precision. The strong stability of CSNs keeps its fluorescence intensity constant as the storage time increases, and even after 6 months of storage, iCSN retains its biological activity when used in test strips (Figure ).
Table 1

Reproducibility Analysis of the iCSN-Based Test Strip

 intra-assay  interassay
SFTSV NP concentrationmeanaSDbCVc (%)meanaSDbCVc (%)
1 μg/mL131.86.04.51459.26.3
10 ng/mL34.61.74.9332.37.0
100 pg/mL9.80.55.1110.98.1
 intra-assay variability 4.8%inter-assay variability 7.1%

Values represent the average of detected fluorescence intensities of parallel samples (n = 3).

Values represent the standard deviation of parallel results (n = 3).

CV = SD/mean.

Figure 8

(A) Fluorescence intensity of the CSNs at different storage times. (B) Stability test of the iCSNs at different storage times.

(A) Fluorescence intensity of the CSNs at different storage times. (B) Stability test of the iCSNs at different storage times. Values represent the average of detected fluorescence intensities of parallel samples (n = 3). Values represent the standard deviation of parallel results (n = 3). CV = SD/mean. Taken together, the above results show that the detection method possessed high sensitivity, high stability, good selectivity, and good reproducibility.

Detection of SFTSV in Human Serums

To evaluate the application of the iCSN-based lateral flow test strip in clinical diagnosis, the immunoassay was extended to the clinical diagnosis of SFTSV in serum as in our previous work.[6] The results of the real-samples analysis (Figure ) are consistent with the results of the polymerase chain reaction and the colloidal gold immunochromatographic test (Table ), indicating that the iCSN-based lateral flow assay of human samples is reliable. Therefore, these results indicated that the iCSN-based lateral flow assay platform may bring a tremendous infusion of promise to the rapid detection of SFTSV in the early stages of the SFTS syndrome.
Figure 9

Fluorescence images (A) and histograms of the intensity of the corresponding T-lines (B) of real samples analysis by the iCSN-based lateral flow test strip.

Table 2

Analysis of SFTSV in Human Serum by the iCSN-Based Lateral Flow Test Stripa

samplecontrol123456 
test results++++++PCR method
 ++++++gold nanoparticles-based test strip[6]
 ++++++our method

Note: (−) negative result, (+) positive result.

Fluorescence images (A) and histograms of the intensity of the corresponding T-lines (B) of real samples analysis by the iCSN-based lateral flow test strip. Note: (−) negative result, (+) positive result.

Ethical Statement

Human serum was collected from 10 mL of peripheral blood from volunteers in the First People’s Hospital of Jiangsu Province, and only applied for scientific research. All protocols involving human subjects were reviewed and approved by the Ethical Committee of the Southeast University in accordance with the Declaration of Helsinki (Association, 2000). Informed consent was obtained from all human subjects enrolled in this study.

Conclusions

In summary, fluorescent CSNs were prepared by co-hydrolysis of silanized CDs and TEOS using cetyltrimethylammonium bromide (CTAB) as a template, and uniform size CSNs were obtained by differential centrifugation. Compared with other fluorescent nanospheres, CSNs synchronously fulfill several criteria: homogeneously distributed CDs within SiO2 templates, uniform dimensions for good reproducibility, convenient surface derivations, relatively simple preparation process, low cost, and environmental friendliness. In addition, it undergoes a strong acid and alkali environment during the synthesis process, but still has a strong quantum yield. The high absolute quantum yields of the CSNs in the aqueous phase and the solid phase make the test strip more sensitive and have a longer assay lifetime. The detection limit of the iCSN-based lateral flow test strip for SFTSV NPs was as low as 10 pg/mL. This is 2 orders of magnitude lower than the SFTSV NPs detected by the test strip of gold colloid as a signal. The assay exhibited a fast, sensitive, and highly selective response to the SFTSV and was applied to the detection of real samples. This assay opens up a new possibility for POC SFTSV detection in daily life. With the continuous expansion of future research, the detection principle can be extended to other virus, protein biomarkers, nucleic acids, and bacteria in clinical diagnosis and a variety of other biomedical applications, which have a wider clinical application prospect.

Experimental Section

Materials and Apparatus

AEAPTMS, citric acid monohydrate, sodium hydroxide, CTAB, TEOS, succinic anhydride, hydrochloric acid (HCl), absolute ethanol, and N,N-dimethylformamide (DMF) were purchased from Sinopharm Chemical Reagent Co., Ltd. N-(3-Dimethylaminopropyl)-N′-ethylcarbodiimide hydrochloride (EDC) was purchased from Energy Chemical Co., Ltd. N-Hydroxysulfosuccinimide sodium salt (NHS) was purchased from Alfa Aesar Chemicals Co., Ltd. 2-(N-Morpholino)ethanesulfonic acid (MES) and 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES) were purchased from Sigma-Aldrich. The H2O used in the experiment was double-distilled H2O. BSA was obtained from Sangon Biotech Co., Ltd. SFTSV NP and SmAb were purchased from Jiangsu Center for Disease Control and Prevention. Goat antimouse IgG antibody, sample pads, NC membranes, absorbent pads, and black plastic adhesive cards were purchased from Shanghai JieYi Biotechnology Co. Ltd. (Shanghai, China). Serums of patients infected with SFTSV and normal human serums were supplied by Jiangsu Province Hospital. Data of serum detection using the PCR method were provided by Jiangsu Province Hospital. In addition, other apparatus are shown in the Supporting Information.

Fabrication of CSNs

At first, silanized CDs were synthesized according to the previous report with slight modifications.[39,46] The specific procedure was as follows: 15 mL of AEAPTMS was poured into a 50 mL three-necked flask and purged with nitrogen for 15 min. The solution was then heated to 240 °C, and 1 g of dehydrated citric acid (pretreatment of citric acid monohydrate in an 80 °C vacuum oven overnight) was quickly added with vigorous stirring. After 5 min, the heating was stopped and the solution was naturally cooled. The obtained CD solution was centrifuged at 10 000 rpm for 10 min to remove large particles at the bottom. Then, CSNs were prepared by the co-hydrolysis method according to the previous report with modification.[39] In brief, CTAB (0.2 g) and NaOH (0.15 mL, 10 M) were added into 99 mL of H2O and stirred at 80 °C for 1 h. A mixture of TEOS (1.2 mL) and CD (0.35 mL) was quickly poured into the solution and allowed to stir at 80 °C for 3 h. The mixture was diluted with ethanol and collected by centrifugation. The precipitate was dispersed in a mixture of HCl (15 mL) and ethanol (120 mL) and stirred at 60 °C for 6 h to extract the residue organic template. The extraction was repeated once and the product was washed to neutral, and finally the aminoterminated CSNs were dispersed in ethanol. Uniform-sized CSNs were obtained by differential centrifugation, that is, by gradually increasing the rotating speed from low to high. First, the CSNs with the largest size were separated from the solution at low speed, and then the liquid was poured into another centrifugal tube to increase the rotating speed and separate the CSNs in second order. With gradually increased rotating speed and repeating the above process, CSNs of size from large to small were obtained from the precipitation of each rotating speed. In order to improve the separation accuracy, the precipitation obtained at each rotating speed was dispersed and centrifuged several times under the same centrifugal conditions (the same speed and time), so that the small particles in the precipitation were gradually removed from the liquid through multiple dispersion, whereas the large particles were always retained in the precipitation. In the specific experimental process, the rotating speeds were 1000, 1500, 2000, 2500 rpm, respectively, the time was 15 min, and the solvent was ethanol. The bottom precipitate at 1000 rpm was discarded and the bottom precipitate at 1500, 2000 and 2500 rpm and the supernatant at 2500 rpm were separately studied.

Fabrication of CSNs–Antibody Conjugates

CSNs obtained at 2500 rpm were used as labels and conjugated to the SmAb. The aminoterminated CSNs were centrifuged and dispersed in DMF at a concentration of 1 mg/mL. Then, CSNs were carboxylated by adding succinic anhydride (5 mg/mL) and stirring for 4 h. The carboxyl-terminated CSNs were washed with ethanol and H2O several times and dispersed in MES buffer (0.01 M, pH = 6.0) for further use. The carboxyl-terminated CSNs were functionalized with SmAb through classical carbodiimide coupling reaction. In brief, 1 mL of CDs/SiO2 spheres (1 mg/mL) in MES buffer (0.01 M, pH = 6.0) was first activated by adding EDC (4 mg) and NHS (6 mg) and reacted for 15 min. The activated particles were washed with water and redispersed in 0.5 mL of HEPES buffer (0.01 M, pH = 7.4). Then, 0.5 mL of SmAb at a concentration of 150 μg/mL was added and incubated at 25 °C for 2 h with gentle agitation. The SmAb-labeled CDs/SiO2, that is, iCSNs were harvested by centrifugation, and redispersed in 1 mL of HEPES buffer (0.01 M, pH = 7.4, containing 1% BSA) to form the storage dispersion and kept at 4 °C.

Lateral Flow Test Strip Preparation

The lateral flow test strip consists of a sample pad (8 × 3 mm), an NC membrane (25 × 3 mm), an absorbent pad (21 × 4 mm), and a black plastic adhesive card. Sample pads were soaked in the treatment solution, which was composed of PBS (10 mM, pH = 7.4) containing 1% (v/v) Tirton X-100 and 2% NaCl, and then dried at 37 °C for 2 h. SmAb (2 mg/mL) and goat antimouse IgG antibody (2 mg/mL) were separately dispersed on the T and C lines of the NC membrane using a double-headed marker (SJ001, Shenzhen Stationery Store) with an extremely small nib (SJ002, 1.97 × 34 mm, Shenzhen Stationery Store) and drying at 37 °C for 2 h. The interval between two lines was 5 mm. The sample pad, NC membrane, and absorbent pad were assembled on the black plastic adhesive card and cut into 3 mm strips. Finally, the strips were kept in an aseptic bag of 4 °C until used.

Detection of SFTSV Using iCSN-Based Lateral Flow Test Strip

The sample (60 μL of SFTSV NP standard solution or serum sample) was mixed with 10 μL of iCSNs in a 0.5 mL centrifuge tube. Then, the mixture was loaded onto the sample pad of the lateral flow test strip, allowing all liquid to be absorbed and migrated along the strip. After 15 min, the results were visually observed under a 360 nm UV lamp in the dry state of the test strip and photographed using an Apple cell phone camera. The images were then digitally processed using ImageJ software to detect the intensity of the T lines in the test strips. The NC film emits blue light under the UV lamp, and the measurement of the light intensity of the T lines subtracted the light intensity of the NC film itself.
  39 in total

1.  Water-soluble fluorescent carbon quantum dots and photocatalyst design.

Authors:  Haitao Li; Xiaodie He; Zhenhui Kang; Hui Huang; Yang Liu; Jinglin Liu; Suoyuan Lian; Chi Him A Tsang; Xiaobao Yang; Shuit-Tong Lee
Journal:  Angew Chem Int Ed Engl       Date:  2010-06-14       Impact factor: 15.336

2.  Cell-targeting multifunctional nanospheres with both fluorescence and magnetism.

Authors:  Hai-Yan Xie; Chao Zuo; Yi Liu; Zhi-Ling Zhang; Dai-Wen Pang; Xiao-Lan Li; Jian-Ping Gong; Calum Dickinson; Wuzong Zhou
Journal:  Small       Date:  2005-05       Impact factor: 13.281

3.  An enhanced strip biosensor for rapid and sensitive detection of histone methylation.

Authors:  Chenchen Ge; Luxin Yu; Zhiyuan Fang; Lingwen Zeng
Journal:  Anal Chem       Date:  2013-09-11       Impact factor: 6.986

4.  Biodegradable polymeric vesicles containing magnetic nanoparticles, quantum dots and anticancer drugs for drug delivery and imaging.

Authors:  Fei Ye; Asa Barrefelt; Heba Asem; Manuchehr Abedi-Valugerdi; Ibrahim El-Serafi; Maryam Saghafian; Khalid Abu-Salah; Salman Alrokayan; Mamoun Muhammed; Moustapha Hassan
Journal:  Biomaterials       Date:  2014-02-01       Impact factor: 12.479

5.  Highly selective detection of phosphate in very complicated matrixes with an off-on fluorescent probe of europium-adjusted carbon dots.

Authors:  Heng Xin Zhao; Li Qin Liu; Zhong De Liu; Yi Wang; Xi Juan Zhao; Cheng Zhi Huang
Journal:  Chem Commun (Camb)       Date:  2011-01-13       Impact factor: 6.222

6.  Fever with thrombocytopenia associated with a novel bunyavirus in China.

Authors:  Xue-Jie Yu; Mi-Fang Liang; Shou-Yin Zhang; Yan Liu; Jian-Dong Li; Yu-Lan Sun; Lihong Zhang; Quan-Fu Zhang; Vsevolod L Popov; Chuan Li; Jing Qu; Qun Li; Yan-Ping Zhang; Rong Hai; Wei Wu; Qin Wang; Fa-Xian Zhan; Xian-Jun Wang; Biao Kan; Shi-Wen Wang; Kang-Lin Wan; Huai-Qi Jing; Jin-Xin Lu; Wen-Wu Yin; Hang Zhou; Xu-Hua Guan; Jia-Fa Liu; Zhen-Qiang Bi; Guo-Hua Liu; Jun Ren; Hua Wang; Zhuo Zhao; Jing-Dong Song; Jin-Rong He; Tao Wan; Jing-Shan Zhang; Xiu-Ping Fu; Li-Na Sun; Xiao-Ping Dong; Zi-Jian Feng; Wei-Zhong Yang; Tao Hong; Yu Zhang; David H Walker; Yu Wang; De-Xin Li
Journal:  N Engl J Med       Date:  2011-03-16       Impact factor: 91.245

7.  Early diagnosis of novel SFTS bunyavirus infection by quantitative real-time RT-PCR assay.

Authors:  Yulan Sun; Mifang Liang; Jing Qu; Cong Jin; Quanfu Zhang; Jiandong Li; Xiaolin Jiang; Qin Wang; Jing Lu; Wen Gu; Shuo Zhang; Chuan Li; Xianjun Wang; Faxian Zhan; Wenqing Yao; Zhenqiang Bi; Shiwen Wang; Dexin Li
Journal:  J Clin Virol       Date:  2011-10-22       Impact factor: 3.168

8.  Lysosome-targeted carbon dots for ratiometric imaging of formaldehyde in living cells.

Authors:  Haifang Liu; Yuanqiang Sun; Zhaohui Li; Jie Yang; Aaron Albert Aryee; Lingbo Qu; Dan Du; Yuehe Lin
Journal:  Nanoscale       Date:  2019-04-25       Impact factor: 7.790

9.  The nucleoprotein of severe fever with thrombocytopenia syndrome virus processes a stable hexameric ring to facilitate RNA encapsidation.

Authors:  Honggang Zhou; Yuna Sun; Ying Wang; Min Liu; Chao Liu; Wenming Wang; Xiang Liu; Le Li; Fei Deng; Hualin Wang; Yu Guo; Zhiyong Lou
Journal:  Protein Cell       Date:  2013-05-23       Impact factor: 14.870

10.  Visual and sensitive detection of viable pathogenic bacteria by sensing of RNA markers in gold nanoparticles based paper platform.

Authors:  Hongxing Liu; Fangfang Zhan; Fang Liu; Minjun Zhu; Xiaoming Zhou; Da Xing
Journal:  Biosens Bioelectron       Date:  2014-06-14       Impact factor: 10.618

View more
  5 in total

Review 1.  Point-of-care diagnostics for infectious diseases: From methods to devices.

Authors:  Chao Wang; Mei Liu; Zhifei Wang; Song Li; Yan Deng; Nongyue He
Journal:  Nano Today       Date:  2021-02-06       Impact factor: 20.722

2.  Fluorescent paper strip immunoassay with carbon nanodots@silica for determination of human serum amyloid A1.

Authors:  Mulya Supianto; Sang Hyuk Lee; Sung Hwa Jhung; Hazara Begum Mohammad; Hung M Vu; Min-Sik Kim; Woo-Young Song; Tae-Young Kim; Hye Jin Lee
Journal:  Mikrochim Acta       Date:  2021-10-18       Impact factor: 5.833

Review 3.  Luminescent Composite Carbon/SiO2 Structures: Synthesis and Applications.

Authors:  Yuliya A Podkolodnaya; Alina A Kokorina; Tatiana S Ponomaryova; Olga A Goryacheva; Daniil D Drozd; Mikhail S Khitrov; Lingting Huang; Zhichao Yu; Dianping Tang; Irina Yu Goryacheva
Journal:  Biosensors (Basel)       Date:  2022-06-06

Review 4.  Recent advances in carbon quantum dots for virus detection, as well as inhibition and treatment of viral infection.

Authors:  Yuxiang Xue; Chenchen Liu; Gavin Andrews; Jinyan Wang; Yi Ge
Journal:  Nano Converg       Date:  2022-04-02

Review 5.  Carbon dots for virus detection and therapy.

Authors:  Jan Belza; Ariana Opletalová; Kateřina Poláková
Journal:  Mikrochim Acta       Date:  2021-11-25       Impact factor: 5.833

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.